Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |